Lower airway immunophenotyping in severe preschool wheeze reveals distinct clusters described by heterogeneity in

Katie L Bonner1, Sara Fontanella1,2, Mindy Gore1,2

  • 1Inflammation Repair and Development Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.

Insights

Recurrent severe wheeze (RSW) in children shows varied airway inflammation. Bacterial infection links to specific neutrophil types, suggesting new treatment strategies for childhood asthma.

Area of Science:

  • Pediatric Pulmonology
  • Immunology
  • Asthma Research

Background:

  • Recurrent preschool wheeze is a major cause of childhood asthma hospitalizations.
  • Current treatments, including inhaled corticosteroids (ICS), are often ineffective for this condition.

Purpose of the Study:

  • To investigate the lower airway immune cell composition in children with recurrent severe wheeze (RSW).
  • To correlate immune cell profiles with infection status, allergic sensitization, and treatment regimens.

Main Methods:

  • Clinical phenotyping and bronchoscopy were performed on 106 children (aged 1-5 years) with RSW.
  • Multi-parameter flow cytometry analyzed blood and bronchoalveolar lavage (BAL) leukocytes.
  • Unsupervised analysis identified distinct clusters of airway inflammation.

Main Results:

  • Immune cell composition was similar between sensitized and non-sensitized children.
  • Non-sensitized children showed higher rates of positive BAL bacterial cultures.
  • Bacterial infection correlated with neutrophils expressing low CD62L and CXCR2; absence of infection showed high expression.
  • Three inflammation clusters emerged: Cluster 1 (infection, CD62Llo neutrophils), Cluster 2 (eosinophil/lymphocyte-rich, CD62Lhi neutrophils), Cluster 3 (low infection, CD62Lhi neutrophils).

Conclusions:

  • Airway inflammation in RSW is heterogeneous, characterized by distinct neutrophil subtypes.
  • Bacterial infection is associated with CD62Llo neutrophils, while other clusters have CD62Lhi neutrophils.
  • Stratifying RSW patients by these identified clusters could lead to novel therapeutic approaches.
Abstract